ロード中...
Linagliptin Increases Incretin Levels, Lowers Glucagon, and Improves Glycemic Control in Type 2 Diabetes Mellitus
INTRODUCTION: Linagliptin is a xanthine-based dipeptidyl peptidase (DPP)-4 inhibitor that is now available in numerous countries worldwide for the treatment of type 2 diabetes mellitus (T2DM). The aim of this study was to evaluate further the mechanisms underlying the improvements in glycemic contro...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Healthcare Communications
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3508116/ https://ncbi.nlm.nih.gov/pubmed/22986920 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-012-0010-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|